Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1 hormone to increase insulin, slow stomach emptying, and reduce appetite.A 2016 landmark SUSTAIN-6 trial, published in The New England Journal of Medicine , found that semaglutide not only reduced HbA1c levels but also led to significant weight reductions and a 26% lower risk of major cardiovascular events in patients with type 2 diabetes
3 Obesity currently affects over one billion individuals worldwide and, in 2024, was directly implicated in over 3.7 million deaths
This was particularly the case among women and older adults
Youll likely notice an improvement in your A1C levels and cholesterol numbers, as well as weight loss
And many people might not be able to tolerate the likely lifetime upkeep of GLP-1 therapy, compared to a single surgery
US$ 20.50
US$ 20.30
US$ 23.01
US$ 20.22
US$ 23.21
